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MaThe assessment of myocardial function in the context of valvular heart disease remains highly challenging. The
myocardium deforms simultaneously in 3 dimensions, and global left ventricular (LV) function parameters such as volume
and ejection fraction may remain compensated despite the changes in myocardial deformation properties. Current
guidelines recommend valve replacement/repair in the presence of symptoms or reduced LV ejection fraction, but the
resolution of symptoms or recovery of LV function post-surgery may not be reliably predicted. A wealth of evidence
currently suggests that LV dysfunction is frequently subclinical despite normal ejection fraction. It may precede the onset
of symptoms and portend a poor outcome due to progressive myocardial remodeling and dysfunction during the post-
operative period. The advent of novel tissue-tracking echocardiography techniques has unleashed new opportunities for
the clinical identiﬁcation of early abnormalities in LV function. This review gathers and summarizes current evidence
regarding the use of these techniques to assess myocardial deformation in patients with valvular heart disease. (J Am
Coll Cardiol Img 2014;7:1151–66) © 2014 by the American College of Cardiology Foundation.V alvular heart disease (VHD) is a commoncause of morbidity and mortality in devel-oping and industrialized countries (1,2).
Aortic stenosis (AS) and primary mitral regurgitation
(MR) are the 2 most common types of VHD (3,4).
The prevalence of these diseases increases sharply
with age, due to the increasing burden of degenera-
tive etiologies seen with gradual increase in life
expectancy.
The assessment of myocardial function in the
context of VHD remains highly challenging. Current
guidelines (3,4) recommend valve replacement/repair
in cases of severe VHD that cause symptoms or
reduced left ventricular ejection fraction (LVEF), but
LVEF is often unable to disclose initial LV dysfunc-
tion in these patients. Assessment of LV deforma-
tion using echocardiography or cardiac magnetic
resonance (CMR) allows for the dynamic imaging of
the heart and provides a window to study regional
and global LV function. Between these 2 techniques,
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Echocardiographic techniques such as tissue Doppler
imaging (TDI) are widely available and allow for
the measurement of tissue velocities within the
myocardium and the assessment of LV function and
ﬁlling pressures (7). However, TDI is largely angle-
dependent, and it only measures a single compo-
nent of the regional velocity vector along the scan
line (8). Speckle tracking echocardiography (STE) is
a relatively newer technique that provides non-
Doppler, relatively angle-independent measurement
of myocardial deformation and LV systolic and dia-
stolic dynamics (8,9). By estimating spatial gradients
in myocardial velocities between features (i.e., the
“speckles”) oriented in the same plane and at a
known distance apart, STE allows for the semi-
automated quantiﬁcation of myocardial deformation
(strain and strain rate) in the 3 spatial directions
(longitudinal, radial, and circumferential) and a
concomitant evaluation of LV mechanics, rotation,
and torsion (8,10–12). Such an approach in assessinges, Laboratiore Traitement du Signal et de l’Image,
ersité Rennes 1, Rennes, France; yDepartment of
ée—Cardiovascular Sciences, Centre Hospitalier
nd the zCardiac Ultrasound Research and Core Lab,
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, accepted July 24, 2014.
ABBR EV I A T I ON S
AND ACRONYMS
AS = aortic stenosis
AVR = aortic valve
replacement
CMR = cardiac magnetic
resonance
ESD = end-systolic diameter
GLS = global longitudinal
strain
LF = low ﬂow
LG = low gradient
LV = left ventricle
LVEF = left ventricular
ejection fraction
LVESD = left ventricular
end-systolic diameter
MR = mitral regurgitation
MS = mitral stenosis
RV = right ventricular
STE = speckle tracking
echocardiography
TDI = tissue Doppler imaging
VHD = valvular heart disease
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1152the components of LV contraction is impor-
tant because subclinical LV dysfunction is
related to alterations in the structure-
function relationship and can manifest in $1
direction before the development of abnor-
malities on conventional measures of LV
performance, such as LVEF (13). Although
STE is particularly suited for the estimation
of systolic function, strain parameters are all
partially load-dependent (14). Some studies
based on complex mathematical models have
shown that peak strain values increase with
increasing pre-load as long as contractile
function is preserved, whereas peak systolic
strain decreases both with increasing ven-
tricular size and afterload (15,16). With
respect to strain, strain rate is less dependent
on pre-load and afterload, being closest to a
representation of regional contractile func-
tion (15,16). Nevertheless, strain rate curves
are highly dependent on insonation meth-
odology and acquisition frame. Strain rate
curves can be noisy (12) and therefore difﬁ-
cult to interpret and apply in routine clinical
practice compared to global longitudinalstrain (GLS).
This review organizes the evidence regarding the
role of deformation imaging and its incremental value
beyond conventional measures of LV function in pa-
tients with VHD and suggests that the application of
these techniques in current clinical practice might
provide some useful tools for the evaluation of pa-
tients with VHD, particularly in the case of preserved
LVEF and mild or no symptoms.
Some recent studies regarding the assessment
of rotation and torsion in VHD are also cited,
but their data should be evaluated cautiously
because the number of patients studied has been
limited. The subsequent sections are thus mainly
focused on the utility of STE strain for quantitative
assessment of myocardial function (longitudinally
in particular). Anyway, the deﬁnition of absolute
values of STE strain magnitude require cautious
interpretation in relation to the LV geometrical al-
terations, loading conditions, presence of dyssyn-
chrony, and segmental interactions that can alter LV
strain magnitudes. Moreover, the lack of standardi-
zation of speckle-tracking algorithms among ven-
dors make it difﬁcult to compare or establish cutoff
values for LV strain (8). The growing interest of
professional societies in this ﬁeld and the call for a
standardization of STE analysis software (8) will
lead to a lower variability and a wider use of strain
in clinical practice.PRIMARY MITRAL REGURGITATION
Degenerative MR (valve prolapses or ﬂail leaﬂets)
is a common and progressive valve disease that is
difﬁcult to manage. Current recommendations (3,4)
advocate surgery in symptomatic patients with se-
vere MR or in asymptomatic patients with early
signs of LV systolic dysfunction (LVEF <60%; end-
systolic diameter [ESD] >40 to 45 mm), atrial ﬁbril-
lation, or pulmonary artery hypertension. Valve
repair is considered reasonably low risk in asymp-
tomatic patients with preserved LVEF, but the
optimal timing of this procedure remains controver-
sial (17–19). Indeed, surgery always carries risk, even
if it is small (an operative mortality of approximately
1%) (20,21), and the durability of valve repair is not
guaranteed. The reported rate of recurrent MR
(grade $1) accounts for 8.3% per year (22), and the
documented late progression to moderate or severe
MR is approximately 7.7% (23). Reduced LVEF is a
powerful predictor of post-operative LV dysfunction
and subsequent cardiac morbidity and mortality
(24,25), but a marked drop in LVEF can occur after
surgery, even when the pre-operative LVEF is normal
(26). The LVEF is often overestimated in the presence
of MR, because it simply reﬂects the entrance and
exit of blood in the LV. Therefore, LVEF may remain
in the normal or supernormal range for long periods
of time, even if alterations in contractility develop.
Therefore, the earlier detection of LV contractile
dysfunction is of pivotal importance and favors the
surgical correction of chronic MR in a timely manner,
which theoretically restores normal LV function and
life expectancy after surgery (26,27). Unfortunately,
this target remains challenging, and the best pre-
dictors of post-operative LV function deterioration
are subject to debate (28). In a recent retrospective
study of 335 patients with severe MR and preserved
LVEF, Tribouilloy et al. (17) showed that the com-
bined evaluation of pre-operative LVEF and LVESD
had an additive value for the prediction of post-
operative LV dysfunction, with the lowest frequency
observed in patients with pre-operative LVEF $64%
and pre-operative LVESD <37 mm. Even if these
parameters can be obtained easily using standard
transthoracic echocardiography, the sensitivity and
speciﬁcity of these techniques were quite low (area
under the curve of 0.69 and 0.64, respectively),
which supports the search for more reliable markers
of LV systolic function. Interestingly, the subtle
alterations of LV function observed in MR may be
associated with the development of pressure half-
time (PHT) during exercise (29) and with right ven-
tricular (RV) dysfunction (30), determining a rapid
FIGURE 1 GLS in Patients With Severe Primary MR and Preserved LVEF
These bull’s-eyes show the difference in global longitudinal strain (GLS)
between 2 patients with severe primary mitral regurgitation (MR) and normal
left ventricular ejection fraction (LVEF). The reduced GLS observed in patient
B can be attributed to more advanced disease with subclinical LV dysfunction.
(A) Normal GLS of a 60-year-old female patient with a body surface area
(BSA) of 1.48 m2 and an effective regurgitant oriﬁce (ERO) of 0.61 cm2.
(B) Reduced GLS of a 75-year-old male patient with BSA of 1.7 m2
and ERO of 0.50 cm2. ANT ¼ anterior; INF ¼ inferior; LAT ¼ lateral;
POST ¼ posterior; s0 ¼ maximal mitral annulus systolic velocity at tissue
Doppler; SEPT ¼ septal.
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1153development of symptoms and a poor prognosis.
Moreover, exercise echocardiography can unmask
latent subclinical LV dysfunction in patients in whom
the LV is compensated at rest. The inability to in-
crease LVEF or reduce the end-systolic volume with
stress reﬂects the presence of an impaired contractile
reserve, which inﬂuences prognosis and could be an
indication for early surgery (29,30). These observa-
tions suggest the need to develop more sensitive
indices of heart performance in patients with MR and
to pay particular attention to those parameters that
can indicate an early LV function deterioration.
LONGITUDINAL LV FUNCTION ASSESSMENT USING TDI.
Haluska et al. (31) demonstrated that longitudinal
LV function, as measured by base-apex velocity
gradient with TDI, correlated with contractile reserve
at exercise and was a sensitive marker of latent LV
dysfunction in 86 patients with asymptomatic MR
(31). In a similar population, Agricola et al. (32)
showed that a myocardial systolic velocity measured
at the lateral mitral annulus (s0) #10 cm/s was an
independent predictor of $10% post-operative LVEF
reduction, with a sensitivity and speciﬁcity of 90%
and 85%, respectively.
LONGITUDINAL LV FUNCTION ASSESSMENT USING STE.
It has recently been suggested that imaging defor-
mation detects subclinical LV dysfunction before the
development of abnormalities using conventional
measures of LV performance (16,33). GLS is a highly
feasible and reproducible parameter with good in-
traobserver and interobserver agreements, and it is
well correlated with LVEF estimated by CMR (34).
These characteristics make GLS a suitable candidate
for STE application in routine clinical practice. In 71
patients with degenerative MR and normal LVEF,
Lancellotti et al. (35) observed that left atrial volume,
GLS at rest, and GLS at peak exercise were predictors
of post-operative LV dysfunction (LVEF <50%). Using
a receiver-operating characteristic curve analysis, an
exercise GLS of –18.5% (sensitivity 84.6%, speciﬁcity
76.5%) and an exercise-induced change in GLS
of 1.9% (sensitivity 92.3%, speciﬁcity 73.6%) were
identiﬁed as the best cutoff values for the prediction
of post-operative LV dysfunction (35). In a similar
study, Magne et al. (36) showed that an exercise-
induced improvement in GLS $2% predicted a
2-fold increase in the risk of cardiovascular events,
whereas a 4% increase in LVEF did not affect
the outcome. This discrepancy reﬂects the load
dependency of LVEF, which is inﬂuenced by the
concomitant change in MR severity during exercise
(36). In 88 subjects with severe MR undergoing mitral
valve repair, Mascle et al. (37) showed that patientswho developed post-operative LV dysfunction had a
lower resting GLS. A resting GLS <–18% was an in-
dependent predictor of post-operative LVEF (37).
Witkowski et al. (38) conﬁrmed these results and
found that a pre-operative GLS >–19.9% was the best
predictor of post-operative LV dysfunction. Notably,
pre-operative LVEF in all of these studies was not a
good predictor of LVEF after surgery, which supports
the hypothesis that measuring GLS at baseline and
during exercise may provide more accurate informa-
tion about the presence of contractile reserve and be
better able to predict changes in post-operative LV
function (38) (Figure 1). The interpretation of strain
values may require normalization for the size of the
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FIGURE 2 GLS in a Patient With Severe MS With Respect to a
Normal Subject
These bull’s-eyes show the difference in GLS between a patient with severe
mitral stenosis (MS) (A) and a normal patient (B). Even if in MS the LV
function has been often considered “preserved,” several studies have shown
that a slight reduction in LV performance can be observed. (A) Severe MS of a
55-year-old male patient with BSA of 2.15 m2 and EOA of 1.3 cm2. (B) Normal
subject is a 50-year-old patient with BSA of 1.94 m2 and EOA of 3.5 cm2.
Abbreviations as in Figure 1.
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1155LV cavity and/or loading condition. As evidenced by
Marciniak et al. (39) in patients with mild to severe
MR, deformation parameters remain unchanged due
to a balance of increased stroke volume and pro-
gressively increased LV dimension in the initial phase
of the disease. Later, such a chronic increase in
wall stress will result in myocardial damage and
reduced contractility, causing a fall in peak systolic
deformation indices. Therefore, correcting LV defor-
mation parameters for changes in geometry could
be a sensitive way of detecting very early changes
in contractile function. For example, Donal et al.
(27) found that exercise GLS normalized for LVESD
closely correlated with post-operative LVEF and that
a GLS/LVESD cutoff of –5.7% exhibited good sensi-
tivity and speciﬁcity in predicting post-operative LV
dysfunction.
OTHER COMPONENTS OF LV MECHANICS. The cur-
rent evidence on the incremental assessment of LV
function in circumferential and radial direction in
patients with MR is limited. In a small group of pa-
tients with moderate to severe MR, Zito et al. (40)
observed that circumferential strain has a biphasic
pattern, being enhanced in moderate MR and signif-
icantly reduced in severe MR with respect to normal
subjects. Chronic volume overload states, including
MR, may also show changes in LV twist mechanics. In
cases of absence of any LV remodeling, increased pre-
load leads to an increase in systolic torsion. However,
LV systolic torsional parameters become abnormal
with chronic volume overload. Patients with MR
may show a delayed onset of untwisting, a slower
untwisting during the isovolumic relaxation period,
a loss of the clear distinction between early and
late untwisting phases, and a reduced untwisting
velocity (41). The degree of LV remodeling and the
severity of MR are correlated with LV torsional
parameters. Moderate MR revealed the highest rota-
tional proﬁle and hyperdynamic or supranormal LV
systolic function, and severe MR showed the lowest
rotational proﬁle, which suggests incipient LV dys-
function (42). Delayed untwisting could conceivably
limit the ability of the LV to generate a suction effect
before the onset of ﬁlling (41). Moreover, changes in
LV torsion may vary transmurally, and such changes
are limited to the endocardial region in general.
The epicardial rotation may not change signiﬁcantly
despite varying degrees of MR (42). Although pre-
liminary data suggest potential value in LV rotation
as a sensitive marker of incipient LV dysfunction,
further standardization of strain will be required
for routine clinical application (42).
Details of the main cited echocardiographic studies
are summarized in Table 1.MITRAL STENOSIS
LV dysfunction is detected in approximately 25% of
mitral stenosis (MS) patients (43). The ﬁrst studies
conducted using LV catheterization showed that MS
is associated with a reduction in pre-load, indexed
LVEDV, and LVEF (44). The presence of an altered
LV function in these patients was conﬁrmed in later
pioneer echocardiographic studies (45) and by several
later surveys using TDI (46,47). More recently, STE-
based studies have conﬁrmed that MS is character-
ized by a signiﬁcant reduction in LV function, as
demonstrated by the lower value of GLS and global
circumferential strain observed in MS patients com-
pared with normal subjects (43,48). Interestingly,
Sengupta et al. (48) found that these abnormalities
TABLE 2 Echocardiographic Studies in MS
First Author
(Ref. #), Year n MS Degree Symptoms
Balloon Mitral
Valvuloplasty
Stress
Echocardiography/
Exercise Testing
Main
Echocardiographic
Method Used
Comparison of LV
Performance in MS Patients
Versus Normal Patients
McDonald (45), 1976 90 Mild to severe — No No M-mode —
Ozdemir et al. (46), 2010 86 Mild to Severe — No No 2D, TDI LVEF: no difference between groups
Mitral annulus (s0) (cm/s) at:
IVS: 7.2  1.6 vs. 8.6  1.7, p < 0.001
LW: 8.1  1.7 vs. 10.2  1.6, p < 0.001
IW: 7.4  1.5 vs. 9.5  1.5, p < 0.001
AW: 7.8  1.9 vs. 10.5  1.7, p < 0.001
Ozer et al. (47), 2004 74 Severe — No No M-mode, 2D, TDI LVEF: no difference between groups
MAPSE (mm):
Septal side: 12  3 vs. 14.4  1.5, p ¼ 0.016
Lateral side: 13.2  3 vs. 16.8  2, p ¼ 0.001
Mitral annulus (s0) (cm/s)
Septal side: 7.6  1.1 vs. 10.4  3.2, p ¼ 0.03
Lateral side: 7.6  1.1 vs. 10.4  3.2, p ¼ 0.003
Bilen et al. (43), 2011 103 Mild to severe — No No 2D, STE* LVEF: no difference between groups
GLS (%): 16.8  1.54 vs. 19.6  2.0, p < 0.001
Sengupta et al. (48), 2014 66 Severe — Yes No 2D, STE† Before mitral balloon valvuloplasty:
LVEF (%): 56.4  7.0 vs. 59.8  3.5, p ¼ 0.01
GLS (%): –14.6  3.3 vs. –20.1  2.3, p < 0.001
GCS (%): –20.0  5.0 vs. –25.7  3.6, p < 0.001
After mitral balloon valvuloplasty:
LVEF (%): 58.2  6.4 vs. 59.8  3.5, NS
GLS (%): –17.8  3.5 vs. –20.1  2.3, p < 0.01
GCS (%): –22.5  4.6 vs. –25.7  3.6, p < 0.01
*STE was performed using EchoPAC (GE Vingmed Ultrasound AS). †The 2D cardiac performance analysis was performed using TomTec Imaging (TomTec Imaging Systems GmbH, Munich, Germany). — ¼ data
were not available or that the category is not applicable.
AW ¼ anterior wall; GCS ¼ global circumferential strain; IVS¼ interventricular septum; IW¼ inferior wall; LW¼ lateral wall; MAPSE¼mitral annular plane systolic excursion; MS¼mitral stenosis; NS¼ not
signiﬁcant; other abbreviations as in Table 1.
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1156are common, with nearly 85% of patients with severe
MS having GLS values corresponding to the lowest
quartile for the control subjects. LV end-diastolic
volume in these patients was the strongest determi-
nant of GLS (48), which suggests that the altered
loading conditions determine the impairment in
LV contractile performance in MS to a great extent
(Figure 2). Several mechanisms have been advocated
to explain the recurrence of LV dysfunction in MS
patients. Rheumatic heart disease is traditionally
considered a pancarditis that affects all layers of the
cardiac chamber walls. However, LV myocardial
biopsies in MS patients have shown a lack of myocyte
damage (49,50) with concomitant ultrastructural
alterations involving myoﬁbril and mitochondrial-
myoﬁbril ratios, which mirror the alterations ob-
served in chronic unloading states (51). An alternative
hypothesis, supported by evidence of postero-basal
wall motion abnormalities in MS patients, is that
the rigid mitral valve apparatus might induce a teth-
ering effect with a subsequent alteration in LV per-
formance (52). More recently, new techniques for
the visualization of intracardiac blood ﬂow (53) have
suggested that the lack of optimal vortex formation
in MS patients might contribute to the development
of LV systolic dysfunction (48) and explain the rapid
recovery of cardiac contractility after mitralvalvuloplasty (48,54). These studies support the hy-
pothesis of a strong relationship between LV ﬂow and
function (55). Although strain data may not be
routinely required in the decisional algorithm for
treatment of MS, it is worth noting that patients with
MS show a decrease in LV systolic function that is
largely reversible.
Details from the major echocardiographic studies
are summarized in Table 2.
AORTIC STENOSIS
AS is a growing health problem (1). Current recom-
mendations (3,4) state that aortic valve replacement
(AVR) is a class I indication in patients with severe
AS and symptoms or reduced LVEF. LVEF is normal
in most patients with AS even when symptoms
develop, and valvular parameters such as aortic
valve area and transvalvular gradients do not pre-
dict clinical outcome after AVR (56). Pibarot and
Dumesnil (57) stated that calciﬁc AS should not be
viewed as an isolated disease that is strictly limited to
the aortic valve but instead as a systemic disease
that often includes an increase in peripheral vascular
resistance caused by atherosclerosis and/or aging and
a concomitant deep alteration in LV structure and
function, even in the presence of a preserved LVEF.
FIGURE 3 GLS in Patients With Severe AS and Various Flow-Gradient Patterns
These bull’s-eyes show the difference in GLS among 3 patients with severe aortic stenosis (AS) but different ﬂow-gradient patterns. The magnitude of
decrease in GLS was almost similar in both low ﬂow–low gradient patients regardless if LVEF was preserved (B) or impaired (C). (A) Normal ﬂow–normal
gradient AS, normal LVEF, and mildly reduced GLS of an 86-year-old male patient with BSA of 1.89 m2, EOA of 0.76 cm2 (0.40 cm2/m2), and LV mass of 101
g/m2. (B) Low ﬂow–low gradient AS, normal LVEF, and severely reduced GLS of an 82-year-old female patient with BSA of 1.77 m2, EOA of 0.75 cm2 (0.42
cm2/m2), and LV mass of 131 g/m2. (C) Low ﬂow–low gradient AS, reduced LVEF, and severely reduced GLS of a 78-year-old male patient with BSA of 1.6 m2,
EOA of 0.53 cm2 (0.33 cm2/m2), and LV mass of 139 g/m2. MG ¼ mean aortic gradient; SGL ¼ strain global longitudinal; SVi ¼ stroke volume index; other
abbreviations as in Figure 1.
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1157FLOW-GRADIENT PATTERNS AND LV LONGITUDINAL
FUNCTION IN AS. As indicated in previous par-
agraphs, LVEF does not estimate the extent of
myocardial dysfunction in patients, especially AS
patients. Dumesnil et al. (58) observed a dichotomy in
the LV contraction of AS patients using a dedicated
M-mode tracing analysis, which suggests that a sig-
niﬁcant decrease in longitudinal contraction was
associated with a substantially normal radial con-
traction and explains the normal LVEF. Laﬁtte et al.
(59) demonstrated that patients with severe AS and
preserved LVEF had lower GLS compared with that of
matched control subjects (–17.8  3.5% vs. 21.1  1.8%;
p < 0.05). This difference was more pronounced in
the basal LV segments. In this study, a basal longi-
tudinal strain >–13% predicted an abnormal exercise
response in AS patients, with a sensitivity and spec-
iﬁcity of 77% and 83%, respectively (an area under the
curve of 0.81, p < 0.01) (59). A lower GLS was also
associated with a higher LV mass index and relative
wall thickness, which supports a direct connection
between concentric remodeling and contractile dys-
function (60). From a physiological point of view,
the pressure overload of AS triggers a continuum
of changes that start from myocyte hypertrophy
and interstitial reactive ﬁbrosis and leads to a self-perpetuating process of cellular atrophy, myocyte
death, and replacement ﬁbrosis to cause a progressive
deterioration of myocardial function and poor prog-
nosis (61). Replacement ﬁbrosis, quantiﬁed by de-
layed gadolinium enhancement, was not reversible
after AVR in 55 patients with symptomatic severe AS
undergoing CMR before and after AVR. In this study,
myocardial ﬁbrosis was associated with reduced pa-
rameters of longitudinal LV systolic function and
portended a poor recovery after AVR, as indicated by
the lack of improvement in New York Heart Associa-
tion functional class in patients with severe ﬁbrosis
(62). Among recent prognostic studies (63–65), a
bicentric study in 163 patients with asymptomatic
moderate to severe AS provided evidence that a
GLS of $–15.9%, a peak transvalvular aortic velocity
$4.4 m/s, a valvuloarterial impedance >4.9 mm Hg/
ml/m2, and an indexed left atrial area $12.2 cm2/m2
were the only signiﬁcant predictors of adverse events,
which were deﬁned as the occurrence of symptoms,
AVR, or death (63) (Figure 3).
The alterations in LV contractility described in
the presence of a preserved LVEF can contribute to
explaining the discrepancies between aortic gradient
and aortic surface observed in some patients with
AS. As evidenced by Hachicha et al. (56), under the
FIGURE 4 Classiﬁcation of AS According to Different Flow-Gradient Patterns
The diagram illustrates the classiﬁcation of AS according to different ﬂow-gradient patterns. AVA ¼ aortic valve area; LF ¼ low ﬂow; LG ¼ low
gradient; NF ¼ normal ﬂow; NG ¼ normal gradient; other abbreviations as in Figures 1 and 3.
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1158denomination of severe AS, it is possible to identify
4 ﬂow-gradient patterns (Figure 4). According to this
classiﬁcation, the presence of a paradoxical low-ﬂow
(LF) pattern—namely, a stroke volume unexpectedly
reduced despite preserved LVEF—is consistent with a
more advanced stages of the disease, characterized by
greater concentric LV remodeling, smaller LV cavity,
extensive LV ﬁbrosis, increased afterload, higher risk
of developing myocardial dysfunction and symp-
toms, more elevated brain natriuretic peptide plasma
levels, and higher mortality rate (57,66–68). As de-
monstrated by Adda et al. (68), in 340 patients with
AS and preserved LVEF, AS was associated with
a reduction in GLS with respect to the referral limit
of –20%, but longitudinal LV dysfunction was partic-
ularly severe in AS patients with LF. Patients with
LF–low gradient (LG) AS showed a signiﬁcant reduc-
tion in basal longitudinal strain compared with pa-
tients with a normal ﬂow–high gradient (–11.6  3.4%
vs. –13.6  3.2%, p < 0.05) and normal ﬂow–LG AS
(–11.6  3.4% vs. –14.8  3.0%, p < 0.001). These
patients also had an increased ventriculoarterial
impedance, which conﬁrms the presence of a greater
hemodynamic impairment and LV dysfunction (68).
In a recent study by Eleid et al. (69), in 1,704 patients
with an aortic valve area <1 cm2 and normal LVEF
grouped according to ﬂow status, an LF-LG pattern
was the strongest predictor of mortality inmultivariable analyses in patients undergoing medi-
cal therapy or AVR. In 639 high-risk patients un-
dergoing transcatheter aortic valve replacement, Le
Ven et al. (70) observed that LF was an independent
predictor of 30-day mortality, cumulative all-cause
mortality, and cumulative cardiovascular mortality
in multivariable analyses, but that LVEF and mean
gradient were not predictors. The higher mortality
observed in patients with LF-LG AS is irrespective of
treatment and LVEF, which indicates the presence of
a syndrome in which the disease is not limited to the
calciﬁc aortic valve but also involves increased arte-
rial afterload and abnormal ventricular dynamic
properties. All of these data support the hypothesis
that the common denominator of severe AS includes
subjects with different degrees of LV functional im-
pairment and disease severity. A careful character-
ization of each patient that involves integrating the
ﬂow pattern evaluations and quantifying the periph-
eral resistances and longitudinal deformation pa-
rameters might allow the identiﬁcation of subjects
with greater disease severity who might beneﬁt from
more strict follow-up or early surgery. All current
evidence points out that GLS is impaired by the in-
crease in afterload. Presence of higher GLS in the face
of increased LV afterload should suggest rela-
tively compensated myocardial contractile function,
whereas a reduced GLS may correlate with the risk
FIGURE 5 Changes in LV Circumferential Strain, Rotation, and Torsion in a Patient With Severe AS
Example of the changes in LV circumferential strain, rotation, and torsion in a patient with severe aortic valve stenosis. The deformation components are
obtained before and after successful transarterial implantation of a percutaneous aortic valve. AS ¼ aortic stenosis; LV ¼ left ventricular; TAVR ¼ trans-
catheter aortic valve replacement.
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1159of symptom development, irreversible myocardial
damage, and increased myocardial ﬁbrosis. Moreover,
because wall stress is maximal at the basal segments
of the LV septum, assessment of LV strain from the
basal segments might provide a useful estimate of
the magnitude of LV contractile abnormalities in
hemodynamically severe AS.
OTHER COMPONENTS OF LV MECHANICS. In a pop-
ulation of 173 patients with asymptomatic AS,
circumferential strain and left atrial size were inde-
pendently associated with increased global LV load
(71). The potential incremental value of circumfer-
ential strain in patients with AS needs to be conﬁrmed
in future studies. LV rotation parameters may be
altered in AS patients with preserved LVEF. Typically,
LV basal rotation is reduced, and apical rotation isincreased, which leads to the overall increase in LV
torsion (72). The increased apical rotation contributes
to the maintenance of LVEF in the normal range, but
it is also associated with a signiﬁcant prolongation of
the apical back-rotation during the LV ﬁlling phase,
which contributes to progressive diastolic dysfunc-
tion, increases in LV ﬁlling pressure, elevations in
brain natriuretic peptide plasma levels, and symptom
development (72,73). However, the concomitant re-
duction in basal rotation might be related to the
augmented wall stress in the basal wall or to the
development of myocardial ﬁbrosis, which are more
evident in these myocardial segments (74) (Figure 5).
Quantiﬁcation of LV rotation or twist deformations
seem promising, because these tools allow the diag-
nosis of incipient LV systolic dysfunction as well as
the estimation of diastolic ﬁlling capabilities.
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FIGURE 6 GLS in Patients With AR and Preserved LVEF
(A) Moderate aortic regurgitation (AR) of an 80-year-old male patient with
BSA of 1.92 m2 and ERO of 0.29 cm2. (B) Severe AR of a 75-year-old male
patient with BSA of 2.02 m2 and ERO of 0.6 cm2. LVEDD ¼ left ventricular
end-diastolic diameter; LVEDV ¼ left ventricular end-diastolic volume; other
abbreviations as in Figure 1.
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1161Nevertheless, the experience in this ﬁeld remains
limited. Moreover, the repeatability and precision of
circumferential strain, rotation, and twist is currently
restricted by the limited lateral spatial resolution and
the presence of through-plane motion in the short
axis. Future studies employing 3-dimensional STE
may circumvent some of these limitations and require
further consideration (75). Details from the major
echocardiographic studies are summarized in Table 3.
AORTIC REGURGITATION
Aortic regurgitation (AR) causes a chronic volume
overload in the LV, which leads to progressive LV
enlargement and LV dysfunction. Current guidelines
indicate surgery in symptomatic patients with severe
AR or, in the case of asymptomatic patients, when
LVESD is >55 mm (25 mm/m2) or LVEF decreases
below 50% (3,4). Despite these indications, the op-
timal timing of cardiac surgery for chronic AR remains
challenging because the development of systolic
dysfunction precedes symptom onset in more than
one-fourth of patients with this condition (76). These
factors arise because the increased LV end-diastolic
volume and eccentric hypertrophy act as compensa-
tory mechanisms for long periods of time, which
masks the development of afterload mismatch and
the progressive exhaustion of myocardial contractile
reserve. Therefore, more sensitive parameters of LV
function evaluation are needed.
LONGITUDINAL LV FUNCTIONASSESSMENT BY TDI. Some
studies have shown that the measure of mitral
annular plane systolic excursion using M-mode and s0
by TDI detect early LV impairment in AR. Vinereanu
et al. (77) showed that patients with asymptomatic
severe AR and reduced functional reserve during ex-
ercise have signiﬁcantly lower mitral annular plane
systolic excursion (11  2 mm vs. 14  2 mm, p < 0.01)
and s0 (8.6  0.6 cm/s vs. 11.9  2.2 cm/s, p < 0.001)
than did subjects with a preserved LV response. In
this small population (n ¼ 21), a resting s0 <9.5 cm/s
was the best determinant of poor exercise tolerance
with a sensitivity and speciﬁcity of 90% and 100%,
respectively (77). Patients with an s0 < 9 cm/s also
presented higher LV wall stress and end-diastolic
pressure (78) and signiﬁcantly increased LV di-
ameters, volume, and mass at a 12-month follow-
up, with a concomitant reduction in longitudinal
shortening and LVEF. Interestingly, a cutoff value of
6.25 cm/s in patients with s0 <9 cm/s predicted AVR
within the year with a good accuracy (79).
LONGITUDINAL LV FUNCTION ASSESSMENT USING STE.
Stefani et al. (80) found that longitudinal strain inthe basal lateral wall in young athletes with bicuspid
mild AR was at the lower extremes of normality
with a marked reduction from the basal to the
mid-apical segments (–14.2  2.2% vs. –18.8  4.2%,
p < 0.001). The ﬁrst study to comprehensively
compare newer echocardiographic modalities for the
detection of LV dysfunction in chronic AR was per-
formed by Olsen et al. (81) in 64 patients with mod-
erate to severe AR. In this population, the GLS, peak
systolic strain rate, and peak diastolic strain rate were
signiﬁcantly lower in patients who developed heart
failure, but no differences in TDI parameters were
observed. All speckle-tracking measures were sig-
niﬁcantly associated with outcomes regardless of
the therapeutic approaches, and TDI velocities were
associated with outcomes after AVR. In medically
treated patients, a GLS of –18% was the best cutoff
for the identiﬁcation of disease progression, and a
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FIGURE 7 Potential Role of GLS in Management of Patients
With Primary MR
Algorithm depicting the potential role of GLS in the clinical management of
patients with primary mitral regurgitation (MR). AF ¼ atrial ﬁbrillation; LA ¼
left atrium; LVESD ¼ left ventricular end-systolic diameter; MVR ¼ mitral
valve replacement/repair; post-OP ¼ post-operative; sPAP ¼ systolic pul-
monary artery pressure; other abbreviations as in Figure 1.
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1163cutoff of –14% was predictive of poor outcome in
patients undergoing AVR (81). These results were
reinforced by Smedsrud et al. (82) who demonstrated
a reduction in GLS in 47 patients with severe AR
compared with healthy control subjects (–17.5  –3.1%
vs. –22.1  1.8%, p < 0.01), even in the presence of
a preserved LVEF (Figure 6). In a recent study,
Kusunose et al. (83) showed that in patients with
moderate to severe AR, resting LV strain (chi-
square ¼ 30.1, p ¼ 0.001), exercise tricuspid
annulus plane systolic excursion (chi-square ¼ 64.4,
p < 0.001), and RV strain at rest (chi-square ¼ 49.7,
p < 0.001) were all independent predictors of early
AVR. In patients with AR, the compensatory increase
in stroke volume consequent to the augmented vol-
ume load and increased sphericity of the LV is re-
sponsible for the prolonged maintenance of global
circumferential function and LVEF in AR patients.
At this early stage, as already observed in MR pa-
tients, the decrease in LV function starts in the sub-
endocardium, where longitudinal myocardial ﬁbers
are more abundant, and determines a consequential
reduction in longitudinal myocardial function (42),
making strain parameters useful to detect LV dys-
function at an earlier stage than LVEF can be detec-
ted. The concomitant evidence that alteration in RV
function may inﬂuence prognosis in AR is in line
with the observations made in patients with severe
MR (30) and suggests that RV function should be
assessed during the clinical evaluation of AR patients.
OTHER COMPONENTS OF LV MECHANICS. Few stu-
dies have been performed on LV rotation. However, a
decrease in LV torsion has been observed in patients
with severe AR with mainly a decrease in LV basal
rotation. In contrast, patients with a moderate AR
generally have an increase in apical rotation, espe-
cially if they do not have hypertension. In regard to
circumferential and radial strain, the data are scarce;
if there are alterations due to the AR, these alterations
are less clear and pronounced than are the observed
alterations in the longitudinal direction (84). Details
of the major echocardiographic studies are summa-
rized in Table 4.
CONCLUSIONS AND FUTURE DIRECTIONS
VHD occurs less frequently than coronary artery dis-
ease, heart failure, or hypertension, but it represents
a major health problem in Western countries, with
an increasing prevalence in an aging population. As
indicated by the results of the Euro Heart Survey,
further efforts should be undertaken to reach an
optimal adherence to guidelines in VHD in symp-
tomatic and asymptomatic patients. Interestingly, atendency toward early intervention in asymptomatic
or mildly symptomatic patients was found in this
survey, which reveals the need for studies aimed at
identifying the effective beneﬁts of an early surgery
strategy.
This challenging perspective is of paramount sig-
niﬁcance if we consider that subclinical LV dysfunc-
tion—intrinsic myocardial dysfunction despite normal
LVEF—in VHD patients may be present before the on-
set of symptoms, which portends a dismal prognosis.
All of these observations highlight the major
need to use more robust parameters to assess LV
function, particularly in the case of preserved LVEF.
Although some limitations were indicated previously,
2-dimensional STE longitudinal strain is highly re-
producible and accurate and has proven to be clini-
cally valuable and reliable, therefore representing
an interesting alternative to the measurement of
LVEF. Conversely, circumferential and radial strains,
and rotation and torsion, are less reproducible and
not yet ready for clinical applications.
FIGURE 8 Potential Role of GLS in the Management of Patients With Severe AS According to Flow-Gradient Pattern
Algorithm depicting the potential role of GLS in the clinical management of patients with severe AS according to ﬂow-gradient pattern. HG ¼
high gradient; other abbreviations as in Figures 1, 3, 4, and 5.
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1164The present review has gathered all the available
evidence that supports the incremental value of GLS
in the diagnostic workup of VHD, especially in the
setting of primary MR (Figure 7) and AS (Figure 8). To
deeply anchor the role of deformation imaging in the
clinical algorithm evaluation of VHD, development
of further large prospective trials and registries are
needed. For example, registries such as the HAVEC
(HeArt ValvE Clinic International Database) registry,
set up by Lancellotti et al. (personal communication,
2014) in the European Union and the United States,
will allow substantial contributions to the ﬁeld.Meanwhile, continued efforts on the standardization
of 2-dimensional STE analysis for mitigating ven-
dors’ differences and widespread education of the
cardiology and surgical fraternity regarding the in-
cremental value of strain imaging beyond EF will
enable routine acceptance of 2-dimensional STE
for the clinical assessment of patients with VHD.
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